Tellurium causes dose-dependent coordinate down-regulation of myelin gene expression

Molecular Brain Research

Volumn 49, Issue 1-2, 1997, Pages 113-119

  Toews, Arrel D ^a   Roe, Elaine B ^a   Goodrum, J F ^a   Bouldin, T W ^a   Weaver, J ^a   Goines, N D ^a   Morell, P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Demyelination; Macrophage; NGF receptor; Peripheral neuropathy; Tellurium

Indexed keywords

CERAMIDE; CHOLESTEROL; GALACTOSYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LYSOZYME; MESSENGER RNA; MYELIN PROTEIN; NERVE GROWTH FACTOR RECEPTOR; SQUALENE MONOOXYGENASE; TELLURIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DEMYELINATION; DOSE TIME EFFECT RELATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; MALE; MYELINATION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SCHWANN CELL; SCIATIC NERVE;

ACETATES; ANIMAL FEED; ANIMALS; CHOLESTEROL; GENE EXPRESSION REGULATION; HYDROXYMETHYLGLUTARYL COA REDUCTASES; KINETICS; MALE; MYELIN P0 PROTEIN; MYELIN PROTEINS; OXYGENASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SCHWANN CELLS; SCIATIC NERVE; SQUALENE; SQUALENE MONOOXYGENASE; TELLURIUM; TIME FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0030656244     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00132-0     Document Type: Article

References (36)

1. Bednarczuk T.A., Wiggins R.C., Konat G.W. Generation of high efficiency, single-stranded DNA hybridization probes by PCR. BioTechniques. 10:1991;478.
2. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
3. Conti G., Baron P.L., Scarpini E., Vedeler C., Rostami A., Pleasure D., Scarlato G. Low-affinity nerve growth factor receptor expression in sciatic nerve during P2-peptide induced experimental allergic neuritis. Neurosci. Lett. 199:1995;135-138.
4. Day R., Gebhard R.L., Schwartz H.L., Strait K.A., Duane W.C., Stone B.G., Oppenheimer J.H. Time course of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and messenger ribonucleic acid, biliary lipid secretion, and hepatic cholesterol content in methimazole-treated hypothyroid and hypophysectomized rats after triiodothryonine administration: possible linkage of cholesterol synthesis to biliary secretion. Endocrinology. 125:1989;459-468.
5. Friede R.L., Brüch W. Macrophage functional properties during myelin degradation. Adv. Neurol. 59:1993;327-336.
6. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature (London). 343:1990;425-430.
7. R.M. Gould, K.R. Jessen, R. Mirsky and G. Tennekoon, The cell of Schwann: an update, in: R.E. Martenson (Ed.), Myelin: Biology and Chemistry, CRC, Boca Raton, FL, 1992, pp. 121-171.
8. Griffin J.W., George R., Ho T. Macrophage systems in peripheral nerves. A review. J. Neuropathol. Exp. Neurol. 52:1993;553-560.
9. 0 and MBP gene expression after crush-injury of the adult peripheral nerve. Mol. Brain. Res. 4:1988;133-141.
10. Gupta S.K., Poduslo J.F., Dunn R., Roder J., Mezei C. Myelin-associated glycoprotein gene expression in the presence and absence of Schwann cell-axonal contact. Dev. Neurosci. 12:1990;22-30.
11. Harry G.J., Goodrum J.F., Bouldin T.W., Recio M.W., Toews A.D., Morell P. Tellurium-induced neuropathy: metabolic alterations associated with demyelination and remyelination in rat sciatic nerve. J. Neurochem. 52:1989;938-945.
12. Hadjiolov A.A., Georgiev O.I., Nosikov V.V., Yavachev L.P. Primary and secondary structure of rat 28S ribosomal RNA. Nucleic Acids Res. 12:1984;3677-3693.
13. Jansen R., Ledley F.D. Production of high specific activity DNA probes using the polymerase chain reaction. Gene Anal. Techn. 6:1989;79-83.
14. LeBlanc A.C., Poduslo J.F. Axonal modulation of myelin gene expression in the peripheral nerve. J. Neurosci. Res. 26:1990;317-326.
15. Lemke G., Axel R. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell. 40:1985;501-508.
16. Lemke G., Chao M. Axons regulate Schwann cell expression of the major myelin and NGF receptor genes. Development. 102:1988;499-504.
17. T. Maniatis, E.F. Fritsch and J. Sambrook, Molecular Cloning, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1982, pp. 122-123.
18. Pauley R.J., Parks W.P., Popko B.J. Expression and demethylation of germinally-transmitted BALB/c mouse mammary tumor virus DNA in Abelson MuLV B-lymphoid cell lines. Virus Res. 1:1984;381-400.
19. Perry V.H., Brown M.C. Macrophages and nerve regeneration. Curr. Opin. Neurobiol. 2:1992;679-682.
20. Perry V.H., Brown M.C. Role of macrophages in peripheral nerve degeneration and repair. BioEssays. 14:1992;401-406.
21. Raedeke M.J., Misko T.P., Hsu C., Herzenberg L.A., Shooter E.M. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature. 325:1987;593-597.
22. Roberson M.D., Toews A.D., Bouldin T., Weaver J., Goines N., Morell P. NGF-R mRNA expression in sciatic nerve: a sensitive indicator of early stages of axonopathy. Mol. Brain Res. 28:1995;231-238.
23. Rudney H., Panini S.R. Cholesterol biosynthesis. Curr. Opin. Lipidol. 4:1993;230-237.
24. Russell D.W. Cholesterol biosynthesis and metabolism. Caridovasc. Drugs Ther. 6:1992;103-110.
25. Stahl N., Jurevics H., Morell P., Suzuki K., Popko B. Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose: ceramide galactosyltransferase. J. Neurosci. Res. 38:1994;234-242.
26. Stoll G., Li C.Y., Trapp B.D., Griffin J.W. Expression of NGF-receptors during immune-mediated and lysolecithin-induced demyelination of the peripheral nervous system. J. Neurocytol. 22:1993;1022-1029.
27. Toews A.D., Eckermann C.E., Roberson M.D., Lee S.Y., Morell P. Primary demyelination induced by exposure to tellurium alters mRNA levels for nerve growth factor receptor, SCIP, 2′,3′-cyclic nucleotide 3′-phosphodiesterase, and myelin proteolipid protein in rat sciatic nerve. Mol. Brain Res. 11:1991;321-325.
28. Toews A.D., Griffiths I.R., Kyriakides E., Goodrum J.F., Eckermann C.E., Morell P., Thomson C.E. Primary demyelination induced by exposure to tellurium alters Schwann cell gene expression: a model for intracellular targeting of NGF receptor. J. Neurosci. 12:1992;3676-3687.
29. A.D. Toews, G.J. Harry, K.B. Lowrey, D.L. Morgan and R.C. Sills, Carbon disulfide neurotoxicity in rats: IV. Increased mRNA expression of low-affinity nerve growth factor receptor: a sensitive and early indicator of PNS damage, Neurotoxicology (1997, in press).
30. Toews A.D., Hostettler J., Barrett C., Morell P. Alterations in gene expression associated with primary demyelination and remyelination in the peripheral nervous system. Neurochem. Res. 22:1997;1271-1280.
31. Toews A.D., Jurevics H., Hostettler J., Roe E.B., Morell P. Tissue-specific coordinate regulation of enzymes of cholesterol biosynthesis: sciatic nerve vs. liver. J. Lipid Res. 37:1996;2502-2509.
32. Toews A.D., Lee S.Y., Popko B., Morell P. Tellurium-induced neuropathy: a model for reversible reductions in myelin gene expression. J. Neurosci. Res. 26:1990;501-507.
33. Trapp B.D., Hauer P., Lemke G. Axonal regulation of myelin protein mRNA levels in actively myelinating Schwann cells. J. Neurosci. 8:1988;3515-3521.
34. Venezie R.D., Toews A.D., Morell P. Macrophage recruitment in different models of nerve injury: lysozyme as a marker for active phagocytosis. J. Neurosci. Res. 40:1995;99-107.
35. Wagner M., Toews A.D., Morell P. Tellurite specifically affects squalene epoxidase: investigations examining the mechanism of tellurium-induced neuropathy. J. Neurochem. 64:1995;2169-2176.
36. Wagner-Recio M., Toews A.D., Morell P. Tellurium blocks cholesterol synthesis by inhibiting squalene metabolism: preferential vulnerability to this metabolic block leads to peripheral nervous system demyelination. J. Neurochem. 57:1991;1891-1901.